Recombinant antibody having unique glycan profile produced by CHO host cell with edited genome and preparation method thereof
AssigneeBio-Thera Solutions, Ltd.
InventorsChao Qin, Yuanqing Zhou, Cuizhen Xiao
Life of this patent
Estimating the term…
Loading patent…
AssigneeBio-Thera Solutions, Ltd.
InventorsChao Qin, Yuanqing Zhou, Cuizhen Xiao
Estimating the term…
The present invention, in the field of bioengineering and biotechnology, relates to a method for preparing a recombinant antibody with a unique glycan profile produced by a genome-edited CHO host cell. Specifically, according to a method of the present invention, the TALEN technology is used to edit the FUT8 gene in CHO cells that have been adapted for serum-free suspension growth. The edited CHO host cells can produce recombinant antibodies with a unique glycan profile. The unique glycan profile can be characterized by non-fucosylated N-linked oligosaccharide chains of the antibodies, extremely low N-glycosylation heterogeneity and uniform carbohydrate chains. The antibody prepared by the method of the invention exhibit significantly increased ADCC and greater stability.
An antibody, characterized in that the antibody is BAT4306F antibody, wherein the BAT4306F antibody is an anti-CD20 antibody that comprises two light chains each comprising the amino acid sequence of SEQ ID NO:
Dependencies are inferred from the claim text.